Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Study 1 included participants who were unwilling or unable to use PAP therapy, and study 2 included participants who had been using PAP therapy for at least 3 months at screening, and who planned to continue PAP for the duration of the trial
All study panelists received comprehensive training and participated on a voluntary basis after providing informed consent
Used needles should be placed in a designated sharps bin and disposed of according to local council or pharmacy arrangements
Retatrutide is an investigational once-weekly injectable developed by Eli Lilly for obesity, type 2 diabetes, and related metabolic conditions
Always discuss dose changes or discontinuation with your healthcare provider before making adjustments
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
MBio 9:e0239217
US$ 29.18
US$ 25.22
US$ 28.02
US$ 29.36
US$ 22.66
US$ 28.46
US$ 21.75
US$ 22.94
US$ 27.35
